Guillain-Barré syndrome after adoptive cell therapy with tumor-infiltrating lymphocytes

Guillain-Barré syndrome after adoptive cell therapy with tumor-infiltrating lymphocytes

Background Adoptive cell therapy (ACT) using tumor-infiltrating lymphocytes (TILs) is a promising experimental immunotherapy that has shown high objective responses in patients with melanoma. Current protocols use a lymphodepletive chemotherapy before infusion of ex vivo expanded TILs, followed by h...

Full description

Bibliographic Details
Main Authors: Alexandre Harari, Stefan Zimmermann, Maria Ochoa de Olza, Angela Orcurto, Andreas Hottinger, Benita Wolf, Blanca Navarro Rodrigo, Aymeric Auger, Virginie Zimmer, Philippe Gannon, Lana Kandalaft, Lionel Trueb
Format: Article
Language:English
Published: BMJ Publishing Group 2020-07-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/8/2/e001155.full

Internet

https://jitc.bmj.com/content/8/2/e001155.full

Similar Items